Tens of thousands of infants are impacted yearly by prenatal opioid exposure. The term
neonatal opioid withdrawal syndrome (NOWS) is now replacing the more familiar term …

OBJECTIVE We examined weight loss patterns and feeding practices of infants hospitalized
for neonatal opioid withdrawal syndrome (NOWS) managed by the eat, sleep, console …

Opioid use disorders (OUD) during pregnancy are related to neonatal opioid withdrawal
syndrome (NOWS). R, S-methadone used to treat OUD and NOWS can penetrate the …

Cases of neonatal abstinence syndrome (NAS) secondary to in utero opioid exposure have
increased significantly over the past decade, with recent data from the US Pediatric Health …

Infant exposure to drugs of abuse represents a worldwide problem whose extent is difficult to
estimate. Despite the potentially serious health consequences, few data concerning …

The opioid crisis affects pregnant women and their infants. In the past two decades, the
number of infants born with neonatal abstinence syndrome (NAS) has quadrupled causing …

The prevalence of newborns with neonatal abstinence syndrome (NAS) is rising sharply. To
respond to this crisis, our institution re-examined our policies and procedures regarding our …

Opioids are potent analgesics used to manage pain in both young and old, but the
increased use in the pregnant population has significant individual and societal implications …

Background Neonatal withdrawal secondary to in utero opioid exposure is a growing global
concern stressing the psychosocial well-being of affected families and scarce hospital …

Objectives The rise in opioid use among pregnant women has resulted in an increase in the
incidence of neonatal abstinence syndrome (NAS). Despite the focus on opioid use …